Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Axsome Therapeutics, Inc. (AXSM) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Axsome Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1579428.
Total stock buying since 2015: $1,365,192.
Total stock sales since 2015: $39,864,480.
Total stock option exercises since 2015: $3,799,848.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 237,345 | $27,072,351 | 116,687 | $1,593,332 |
| 2024 | 0 | $0 | 134,147 | $10,567,674 | 162,843 | $1,264,635 |
| 2023 | 0 | $0 | 29,588 | $2,224,455 | 11,016 | $40,428 |
| 2022 | 0 | $0 | 0 | $0 | 3,496 | $4,544 |
| 2021 | 10,135 | $373,789 | 0 | $0 | 0 | $0 |
| 2020 | 1,427 | $110,574 | 0 | $0 | 60,186 | $525,423 |
| 2019 | 38,950 | $776,478 | 0 | $0 | 56,620 | $188,148 |
| 2018 | 31,000 | $95,325 | 0 | $0 | 0 | $0 |
| 2017 | 0 | $0 | 0 | $0 | 42,538 | $183,338 |
| 2015 | 1,000 | $9,026 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 0 | $0 | 13,464 | $1,665,227 | 0 | $0 |
| 2025-08 | 0 | $0 | 96,694 | $11,708,615 | 0 | $0 |
| 2025-06 | 0 | $0 | 61,014 | $6,408,496 | 61,014 | $1,277,678 |
| 2025-05 | 0 | $0 | 51,173 | $5,338,483 | 40,673 | $263,154 |
| 2025-02 | 0 | $0 | 15,000 | $1,951,530 | 15,000 | $52,500 |
| 2024-11 | 0 | $0 | 0 | $0 | 33,410 | $198,455 |
| 2024-09 | 0 | $0 | 11,016 | $1,005,870 | 11,016 | $40,428 |
| 2024-08 | 0 | $0 | 47,739 | $4,022,488 | 47,739 | $192,865 |
| 2024-05 | 0 | $0 | 18,407 | $1,376,926 | 13,693 | $17,800 |
| 2024-04 | 0 | $0 | 24,662 | $1,904,942 | 24,662 | $32,060 |
| 2024-03 | 0 | $0 | 32,323 | $2,257,448 | 32,323 | $783,027 |
| 2023-09 | 0 | $0 | 29,588 | $2,224,455 | 11,016 | $40,428 |
| 2022-03 | 0 | $0 | 0 | $0 | 3,496 | $4,544 |
| 2021-11 | 9,635 | $344,714 | 0 | $0 | 0 | $0 |
| 2021-05 | 500 | $29,075 | 0 | $0 | 0 | $0 |
| 2020-06 | 1,427 | $110,574 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 0 | $0 | 60,186 | $525,423 |
| 2019-09 | 2,180 | $54,064 | 0 | $0 | 0 | $0 |
| 2019-07 | 0 | $0 | 0 | $0 | 56,620 | $188,148 |
| 2019-06 | 18,120 | $414,216 | 0 | $0 | 0 | $0 |
| 2019-05 | 8,150 | $177,851 | 0 | $0 | 0 | $0 |
| 2019-03 | 10,500 | $130,347 | 0 | $0 | 0 | $0 |
| 2018-06 | 31,000 | $95,325 | 0 | $0 | 0 | $0 |
| 2017-03 | 0 | $0 | 0 | $0 | 42,538 | $183,338 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | Jeffs Roger | Sale | 13,464 | 123.68 | 1,665,227 |
| 2025-08-29 | Jeffs Roger | Sale | 20,000 | 121.27 | 2,425,400 |
| 2025-08-28 | Jeffs Roger | Sale | 20,000 | 121.60 | 2,432,000 |
| 2025-08-27 | Jeffs Roger | Sale | 20,000 | 122.30 | 2,446,000 |
| 2025-08-26 | Jeffs Roger | Sale | 20,000 | 120.03 | 2,400,600 |
| 2025-08-22 | Jeffs Roger | Sale | 16,694 | 120.08 | 2,004,615 |
| 2025-06-23 | Murdock Hunter R. (General Counsel) | Sale | 6,014 | 100.12 | 602,121 |
| 2025-06-23 | Murdock Hunter R. (General Counsel) | Option Ex | 6,014 | 29.91 | 179,878 |
| 2025-06-20 | Murdock Hunter R. (General Counsel) | Sale | 7,500 | 102.47 | 768,525 |
| 2025-06-20 | Murdock Hunter R. (General Counsel) | Option Ex | 7,500 | 29.91 | 224,325 |
| 2025-06-18 | Murdock Hunter R. (General Counsel) | Sale | 7,500 | 100.90 | 756,750 |
| 2025-06-18 | Murdock Hunter R. (General Counsel) | Option Ex | 7,500 | 29.91 | 224,325 |
| 2025-06-17 | Murdock Hunter R. (General Counsel) | Sale | 7,500 | 100.26 | 751,950 |
| 2025-06-17 | Murdock Hunter R. (General Counsel) | Option Ex | 7,500 | 29.91 | 224,325 |
| 2025-06-16 | Murdock Hunter R. (General Counsel) | Sale | 7,500 | 102.42 | 768,150 |
| 2025-06-16 | Murdock Hunter R. (General Counsel) | Option Ex | 7,500 | 29.91 | 224,325 |
| 2025-06-09 | Jacobson Mark L. (Chief Operating Officer) | Sale | 25,000 | 110.44 | 2,761,000 |
| 2025-06-09 | Jacobson Mark L. (Chief Operating Officer) | Option Ex | 25,000 | 8.02 | 200,500 |
| 2025-05-28 | Jacobson Mark L. (Chief Operating Officer) | Sale | 20,000 | 103.45 | 2,069,000 |
| 2025-05-28 | Jacobson Mark L. (Chief Operating Officer) | Option Ex | 20,000 | 6.47 | 129,400 |
| 2025-05-28 | Coleman Mark | Sale | 3,750 | 103.43 | 387,862 |
| 2025-05-27 | Jacobson Mark L. (Chief Operating Officer) | Sale | 20,673 | 104.66 | 2,163,636 |
| 2025-05-27 | Jacobson Mark L. (Chief Operating Officer) | Option Ex | 20,673 | 6.47 | 133,754 |
| 2025-05-27 | Coleman Mark | Sale | 3,750 | 105.47 | 395,512 |
| 2025-05-20 | Coleman Mark | Sale | 3,000 | 107.49 | 322,473 |
| 2025-02-14 | Pizzie Nick (Chief Financial Officer) | Sale | 3,000 | 131.07 | 393,210 |
| 2025-02-14 | Pizzie Nick (Chief Financial Officer) | Option Ex | 3,000 | 3.50 | 10,500 |
| 2025-02-13 | Pizzie Nick (Chief Financial Officer) | Sale | 12,000 | 129.86 | 1,558,320 |
| 2025-02-13 | Pizzie Nick (Chief Financial Officer) | Option Ex | 12,000 | 3.50 | 42,000 |
| 2024-11-19 | Coleman Mark | Option Ex | 33,410 | 5.94 | 198,455 |
| 2024-09-11 | Saad Mark E | Sale | 11,016 | 91.31 | 1,005,870 |
| 2024-09-11 | Saad Mark E | Option Ex | 11,016 | 3.67 | 40,428 |
| 2024-08-09 | Jacobson Mark L. (Chief Operating Officer) | Sale | 47,739 | 84.26 | 4,022,488 |
| 2024-08-09 | Jacobson Mark L. (Chief Operating Officer) | Option Ex | 47,739 | 4.04 | 192,865 |
| 2024-05-29 | Jacobson Mark L. (Chief Operating Officer) | Sale | 7,910 | 74.31 | 587,815 |
| 2024-05-29 | Jacobson Mark L. (Chief Operating Officer) | Option Ex | 13,693 | 1.30 | 17,800 |
| 2024-05-29 | Coleman Mark | Sale | 5,248 | 75.14 | 394,334 |
| 2024-05-28 | Coleman Mark | Sale | 5,249 | 75.21 | 394,777 |
| 2024-04-01 | Jacobson Mark L. (Chief Operating Officer) | Sale | 24,662 | 77.24 | 1,904,942 |
| 2024-04-01 | Jacobson Mark L. (Chief Operating Officer) | Option Ex | 24,662 | 1.30 | 32,060 |
| 2024-03-15 | Jeffs Roger | Sale | 2,347 | 71.61 | 168,061 |
| 2024-03-15 | Jeffs Roger | Option Ex | 2,347 | 29.91 | 70,198 |
| 2024-03-14 | Jeffs Roger | Sale | 29,976 | 69.70 | 2,089,387 |
| 2024-03-14 | Jeffs Roger | Option Ex | 29,976 | 23.78 | 712,829 |
| 2023-09-15 | Coleman Mark (Director) | Sale | 29,588 | 75.18 | 2,224,455 |
| 2023-09-15 | Coleman Mark (Director) | Option Ex | 11,016 | 3.67 | 40,428 |
| 2022-03-15 | Coleman Mark (Director) | Option Ex | 3,496 | 1.30 | 4,544 |
| 2021-11-19 | Jeffs Roger (Director) | Buy | 3,950 | 37.30 | 147,350 |
| 2021-11-18 | Pizzie Nick (CHIEF FINANCIAL OFFICER) | Buy | 955 | 35.11 | 33,528 |
| 2021-11-18 | Coleman Mark (Director) | Buy | 1,430 | 35.09 | 50,171 |
| 2021-11-17 | Saad Mark E (Director) | Buy | 3,300 | 34.44 | 113,665 |
| 2021-05-12 | Coleman Mark (Director) | Buy | 500 | 58.15 | 29,075 |
| 2020-06-29 | Pizzie Nick (Chief Financial Officer) | Buy | 777 | 76.64 | 59,549 |
| 2020-06-29 | Coleman Mark (Director) | Buy | 650 | 78.50 | 51,025 |
| 2020-01-10 | Jeffs Roger | Option Ex | 60,186 | 8.73 | 525,423 |
| 2019-09-26 | Pizzie Nick (Chief Financial Officer) | Buy | 2,180 | 24.80 | 54,064 |
| 2019-07-03 | Jeffs Roger (Director) | Option Ex | 56,620 | 3.32 | 188,148 |
| 2019-06-26 | Coleman Mark | Buy | 15,800 | 23.10 | 364,980 |
| 2019-06-25 | Coleman Mark | Buy | 400 | 23.25 | 9,300 |
| 2019-06-11 | Pizzie Nick (Chief Financial Officer) | Buy | 1,920 | 20.80 | 39,936 |
| 2019-05-23 | Saad Mark E | Buy | 3,500 | 22.33 | 78,155 |
| 2019-05-13 | Coleman Mark | Buy | 4,650 | 21.44 | 99,696 |
| 2019-03-19 | Pizzie Nick (Chief Financial Officer) | Buy | 5,400 | 12.63 | 68,229 |
| 2019-03-19 | Coleman Mark (Director) | Buy | 5,100 | 12.18 | 62,118 |
| 2018-06-19 | Pizzie Nick (Chief Financial Officer) | Buy | 31,000 | 3.08 | 95,325 |
| 2017-03-29 | Jeffs Roger (Director) | Option Ex | 42,538 | 4.31 | 183,338 |
| 2015-12-23 | Kaye Randall (Chief Medical Officer) | Buy | 1,000 | 9.03 | 9,026 |
Insider trading activities including stock purchases, stock sales, and option exercises of AXSM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Axsome Therapeutics, Inc. (symbol AXSM, CIK number 1579428) see the Securities and Exchange Commission (SEC) website.